Sunday 11 October 2026 Export all OHI data to Excel Powerpack

Omega Healthcare Investors, Inc.

OHI Real Estate Reit Healthcare Facilities

Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024. In the quarter to June 2026, revenue grew 16.2%, EPS grew 163.0%, free cash flow grew 710.6% and total debt fell 99.9%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three; insiders bought in the last twelve months.

44.41 0.27 +0.61%
Market cap
$13.4B
P/E
15.7×
Fwd P/E
22.5×
Dividend yield
6.05%
F-score
6/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions trades per month

Total buys 1.36
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy 2 — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 13,370.00
Revenue 1,282.01
Net Income 895.17
Free Cash Flow 832.24
Net Debt (178.21)
Current Ratio 6.03
Debt/Equity 0.00
P/E ratio 15.70
Fwd P/E 22.50
P/S ratio 10.36 (above 10: high)
P/B ratio 2.35
Past 5Y EPS Growth 22.61% (at or above 15%: strong)
This Y EPS Growth 36.81% (at or above 15%: strong)
Next Y EPS Growth (24.63%) (below 0%: weak)
Next Y revenue growth (8.33%) (below 0%: weak)
Next 5Y EPS Growth 1.48%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 7.64%
10-year low 10-year high
P/S against its own 10 years 86.30%
10-year low 10-year high
P/B against its own 10 years 87.15%
10-year low 10-year high
EV/Sales against its own 10 years 0.22%
10-year low 10-year high
EV/FCF against its own 10 years 0.94%
10-year low 10-year high

Dividends

Payout Ratio 0.96
Annual Dividend Rate 2.69
Annual Dividend Yield 6.05%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 2.71
0.67
0.67
0.68
2025 2.68
0.67
0.67
0.67
0.67
2024 2.68
0.67
0.67
0.67
0.67
2023 2.68
0.67
0.67
0.67
0.67
2022 2.68
0.67
0.67
0.67
0.67
2021 2.68
0.67
0.67
0.67
0.67
2020 2.68
0.67
0.67
0.67
0.67
2019 2.65
0.66
0.66
0.66
0.67
2018 2.64
0.66
0.66
0.66
0.66
2017 2.54
0.62
0.63
0.64
0.65
2016 2.36
0.57
0.58
0.60
0.61
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 445 549 55 184
Receivables 288 345 340 546
Inventory — — — —
Other — — — —
1,944 2,322 1,776 2,097
2023 2024 2025 Q'26
Payables — — — —
ST’ Debt — — — —
Other — — — —
288 328 353 348

Compound Annual Growth %

10y 5y 3y
Sales 4.81% 5.93% 10.66%
Cash Flow 6.93% 4.40% 11.98%
Earnings 10.17% 29.99% 10.46%
Book Value 2.87% 6.15% 12.67%

Revenue $m

Mar Jun Sep Dec Year
’26 323 328 — — —
’25 277 283 312 319 1,190
’24 243 253 276 279 1,051
’23 218 250 242 239 950
’22 249 245 239 145 878
’21 274 257 282 250 1,063
’20 253 256 119 264 892
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 216 218 — — —
’25 182 239 227 231 879
’24 151 184 185 229 749
’23 111 170 171 165 618
’22 132 173 167 154 626
’21 176 202 187 157 722
’20 139 190 181 197 708
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 78 655 — — —
’25 88 (107) 217 (117) 81
’24 117 80 82 (44) 234
’23 92 7 90 84 273
’22 333 211 (264) 51 331
’21 (432) 173 88 137 (34)
’20 98 135 162 102 496
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.47 1.19 — — —
’25 0.33 0.46 0.59 0.55 1.94
’24 0.27 0.45 0.42 0.41 1.55
’23 0.15 0.25 0.37 0.22 1.00
’22 0.79 0.38 0.43 0.19 1.80
’21 0.69 0.36 0.58 0.14 1.75
’20 0.39 0.43 (0.40) 0.27 0.70
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.5
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 26.96 26.43 24.90 33.39 13.33 27.06 24.81 25.61 27.53 35.04

Analyst estimates 2026–2028

Powerpack
High 38.09 35.14 38.34 45.01 45.22 39.31 33.71 34.77 44.42 46.36
People
People Employees 60 59 51 49 68 70 52 57 60 69
Revenue/emp, $m 15.01 15.40 17.29 18.96 13.12 15.18 16.89 16.66 17.52 17.25
Income, $m
Income, $m Revenue 901 908 882 929 892 1,063 878 950 1,051 1,190
Gross margin, % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
EBT 384 106 297 344 162 416 436 256 421 624
EBT margin, % 42.66 11.66 33.63 37.02 18.19 39.15 49.66 26.92 40.02 52.47
Net income 383 105 294 352 164 428 439 249 418 609
Depreciation 265 295 280 305 327 376 340 334 317 326
Per share, $
Per share, $ Revenue 4.70 4.59 4.40 4.35 3.92 4.49 3.72 3.95 4.07 4.08
Earnings 1.91 0.51 1.41 1.60 0.70 1.76 1.81 1.01 1.57 1.96
Cash flow 3.26 2.92 2.49 2.59 3.11 3.05 2.65 2.57 2.90 3.01
Capex (5.58) (2.39) (1.37) (2.67) (0.93) (3.19) (1.25) (1.43) (2.00) (2.73)
Free cash flow (2.32) 0.54 1.12 (0.08) 2.18 (0.14) 1.40 1.13 0.91 0.28
Book value 21.96 19.66 18.80 20.32 17.72 17.34 16.10 15.64 18.33 18.65
Shares, m 192 198 200 213 228 237 236 240 258 292
Valuation, ×
Valuation, × P/E 16.82 54.86 25.11 26.47 51.15 16.72 15.53 31.16 24.11 22.74
P/S 6.80 5.97 7.98 9.73 9.27 6.60 7.52 7.81 9.29 10.87
P/B 1.45 1.40 1.87 2.08 2.05 1.71 1.74 1.97 2.07 2.38
EV/Sales 11.53 10.90 13.12 15.22 14.87 11.52 13.20 12.68 13.37 11.02
EV/FCF (23.37) 93.56 51.42 (848.56) 26.74 (362.68) 34.98 44.15 60.07 161.84
Cash, $m
Cash, $m Operating cash flow 625 578 499 554 708 722 626 618 749 879
Capex (1,069) (472) (274) (570) (212) (756) (294) (345) (515) (797)
Free cash flow (444) 106 225 (17) 496 (34) 331 273 234 81
Balance, $m
Balance, $m Working capital 626 752 484 522 782 1,064 1,262 1,657 1,994 1,423
Total debt 4,367 4,572 4,541 5,136 5,169 5,254 5,287 5,067 4,839 4,256
Net debt 4,260 4,475 4,529 5,103 5,002 5,229 4,986 4,623 4,290 4,201
Shareholders’ equity 4,212 3,888 3,764 4,337 4,037 4,108 3,803 3,762 4,731 5,440
Returns, %
Returns, % ROA 4.33 1.13 3.24 3.71 1.65 4.36 4.61 2.69 4.40 5.93
ROIC 4.13 2.36 3.56 3.28 2.63 3.48 2.22 2.92 4.32 4.65
ROE 8.82 2.48 7.36 8.42 3.81 10.23 11.09 6.59 9.85 11.63
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Omega Healthcare Investors, Inc. vs peers in Reit Healthcare Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
VTR Ventas, Inc. $42.9B 149× 133× +21.73% (above 0%: growing) −6.67% (below 0%: shrinking) +13.60% (above 0%: growing) 95.22% 13.43% Compare
OHI Omega Healthcare Investors, Inc. $13.4B 15.7× 22.5× +16.19% (above 0%: growing) +163.04% (above 0%: growing) +710.56% (above 0%: growing) 100.00% 57.45%
DOC Healthpeak Properties, Inc. $13.1B 53.8× 71.3× +11.12% (above 0%: growing) +60.00% (above 0%: growing) −30.47% (below 0%: shrinking) 56.83% 16.18% Compare
AHR American Healthcare REIT, Inc. $11.1B 74.7× 80.1× +24.29% (above 0%: growing) +166.67% (above 0%: growing) +9.53% (above 0%: growing) 20.35% 6.29% Compare
CTRE CareTrust REIT, Inc. $8.5B 22.7× 25.4× +43.46% (above 0%: growing) +5.56% (above 0%: growing) +88.99% (above 0%: growing) 98.66% 67.53% Compare
HR Healthcare Realty Trust Incorporated $5.9B — (loss-making) — (loss-making) −5.26% (below 0%: shrinking) n/m −28.80% (below 0%: shrinking) 64.88% 13.83% Compare
SBRA Sabra Healthcare REIT, Inc. $4.8B 72.9× 27.3× +24.70% (above 0%: growing) n/m −666.09% (below 0%: shrinking) 100.00% (13.59%) Compare
NHI National Health Investors, Inc. $3.2B 18.7× 20.2× +33.81% (above 0%: growing) +45.57% (above 0%: growing) +2,585.45% (above 0%: growing) 72.18% 41.09% Compare
LTC LTC Properties, Inc. $2.3B 15.5× 18.8× +64.11% (above 0%: growing) +72.73% (above 0%: growing) −213.92% (below 0%: shrinking) 100.00% 31.24% Compare
Median of peers $7.2B 53.8× 27.3× +24.50% +52.78% −9.63% 83.70% 15.01%

All 16 Reit Healthcare Facilities stocks →

Omega Healthcare Investors, Inc. (OHI) key facts

  • Strength: Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024.
  • Omega Healthcare Investors, Inc. (OHI) is a Reit Healthcare Facilities company in the Real Estate sector, listed on the New York Stock Exchange.
  • As of October 9, 2026, OHI traded at $44.41, a market capitalization of $13.4 billion.
  • Omega Healthcare Investors, Inc. pays an annual dividend of $2.69 per share, a yield of 6.05%, with a payout ratio of 96.1%.
  • Return on equity was 11.6% and debt-to-equity 0.00.
  • Its Piotroski F-score is 6 out of 9 for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Omega Healthcare Investors, Inc. (OHI) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/OHI · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com